ENDOTOXIN TOLERANCE ALTERS THERMAL RESPONSE OF GUINEA-PIGS TO SYSTEMIC INFUSIONS OF TUMOR-NECROSIS-FACTOR-ALPHA

被引:30
作者
ROTH, J [1 ]
ZEISBERGER, E [1 ]
机构
[1] UNIV GIESSEN KLINIKUM, INST PHYSIOL, D-35392 GIESSEN, GERMANY
关键词
FEVER; CYTOKINES; LIPOPOLYSACCHARIDE; RADIOTELEMETRY;
D O I
10.1152/ajpregu.1995.268.2.R514
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In guinea pigs, intra-arterial infusions of 5 mu g/kg tumor necrosis factor-alpha (TNF; specific activity 20,000 U/mu g; duration of infusion 45-50 min) evoked a biphasic elevation of abdominal temperature lasting similar to 6 h. One week after systemic infusion of TNF, the animals started to receive either five intramuscular injections of bacterial Lipopolysaccharide (LPS from Escherichia coli; 20 mu g/kg) or equivalent volumes of solvent (0.9% NaCl) in intervals of 3 days. Fever in response to repeated injections of LPS was progressively attenuated; the animals developed endotoxin tolerance. Repeated injections with solvent did not cause any measurable changes in abdominal temperature. Three days after the fifth injection of LPS or solvent, all animals again received an intra-arterial infusion of 5 mu g/kg TNF. In guinea pigs injected five times with solvent, the biphasic elevation of abdominal temperature could again be observed in response to systemic infusions of TNF. In endotoxin-tolerant animals, however, only the first peak of the biphasic thermal response lasting similar to 60 min could be monitored after infusions with TNF. The second phase of the thermal response to administration of TNF, which normally lasts >5 h, was abrogated almost completely. The significant suppression of the febrile response to TNF infusions did not seem to be caused by a more rapid elimination of TNF from the circulation of endotoxin-tolerant guinea pigs. Circulating levels of TNF, measured 60 and 180 min after the start of TNF infusions, were not different before and after development of endotoxin tolerance. In conclusion, the development of endotoxin tolerance in guinea pigs is accompanied by a reduced responsiveness to TNF administered exogenously.
引用
收藏
页码:R514 / R519
页数:6
相关论文
共 31 条
[21]   HUMAN ASTROCYTE PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-BETA, AND INTERLEUKIN-6 FOLLOWING EXPOSURE TO LIPOPOLYSACCHARIDE ENDOTOXIN [J].
SHARIF, SF ;
HARIRI, RJ ;
CHANG, VA ;
BARIE, PS ;
WANG, RS ;
GHAJAR, JBG .
NEUROLOGICAL RESEARCH, 1993, 15 (02) :109-112
[22]   TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA MEDIATE HUMAN ENDOTHELIAL-CELL ACTIVATION IN BLOOD AT LOW ENDOTOXIN CONCENTRATIONS [J].
PUGIN, J ;
ULEVITCH, RJ ;
TOBIAS, PS .
JOURNAL OF INFLAMMATION, 1995, 45 (01) :49-55
[23]   ANTIBODY-RESPONSE AGAINST TETANUS TOXOID IS ENHANCED BY LIPOPOLYSACCHARIDE OR TUMOR-NECROSIS-FACTOR-ALPHA IN VITAMIN-A-SUFFICIENT AND DEFICIENT RATS [J].
ARORA, D ;
ROSS, AC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1994, 59 (04) :922-928
[24]   Systemic administration of an anti-tumor necrosis factor-alpha monoclonal antibody protects against endotoxin-induced uveitis in rats [J].
Ge, Qingman ;
Wang, Shaocheng ;
Zheng, Yuezhong .
INDIAN JOURNAL OF OPHTHALMOLOGY, 2016, 64 (12) :873-877
[25]   SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS DEMONSTRATE ENHANCED IGG BINDING TO ENDOTHELIAL-CELLS PRETREATED WITH TUMOR-NECROSIS-FACTOR-ALPHA [J].
QUADROS, NP ;
ROBERTSTHOMSON, PJ ;
GALLUS, AS .
RHEUMATOLOGY INTERNATIONAL, 1995, 15 (03) :99-105
[26]   ENHANCEMENT OF PLASMA-LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA BUT NOT INTERLEUKIN-6 FOLLOWING ENDOTOXIN INJECTION OF FRIEND-LEUKEMIA VIRUS-INFECTED MICE [J].
SOLDAINI, E ;
BALDINOTTI, F ;
MATTEUCCI, D ;
SPECTER, S ;
BENDINELLI, M .
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1994, 8 (01) :25-31
[27]   Acute-phase gene expression correlates with intrahepatic tumor necrosis factor-alpha abundance but not with plasma tumor necrosis factor concentrations during sepsis systemic inflammatory response syndrome in the rat [J].
Andrejko, KM ;
Deutschman, CS .
CRITICAL CARE MEDICINE, 1996, 24 (12) :1947-1952
[28]   Regulation of the gene encoding tumor necrosis factor alpha (TNF-α) in the rat brain and pituitary in response to different models of systemic immune challenge [J].
Nadeau, S ;
Rivest, S .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (01) :61-77
[29]   MODULATION OF THE ENDOTHELIAL PROCOAGULANT RESPONSE TO LIPOPOLYSACCHARIDE AND AND TUMOR-NECROSIS-FACTOR-ALPHA IN-VITRO - THE EFFECTS OF DEXAMETHASONE, PENTOXIFYLLINE, ILOPROST AND A POLYCLONAL ANTI-HUMAN IL-1-ALPHA ANTIBODY [J].
HEYDERMAN, RS ;
KLEIN, NJ ;
DARAMOLA, OA ;
LEVIN, M .
INFLAMMATION RESEARCH, 1995, 44 (07) :275-280
[30]   CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK [J].
DHAINAUT, JFA ;
VINCENT, JL ;
RICHARD, C ;
LEJEUNE, P ;
MARTIN, C ;
FIEROBE, L ;
STEPHENS, S ;
NEY, UM ;
SOPWITH, M ;
MERCAT, A ;
EDOUARD, A ;
FRIEDMAN, G ;
MARIN, N ;
SCHLEMMER, B ;
LEPAPE, A ;
NOVAK, C .
CRITICAL CARE MEDICINE, 1995, 23 (09) :1461-1469